Young coconut juice, a potential therapeutic agent that could significantly reduce some pathologies associated with Alzheimer's disease: Novel findings

British Journal of Nutrition

Volumn 105, Issue 5, 2011, Pages 738-746

  Radenahmad, Nisaudah ^a   Saleh, Farid ^b   Sawangjaroen, Kitja ^a   Vongvatcharanon, Uraporn ^a   Subhadhirasakul, Patchara ^a   Rundorn, Wilart ^a   Withyachumnarnkul, Boonsirm ^c   Connor, James R ^d  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^b KUWAIT UNIVERSITY   (Kuwait)

^c Mahidol University ^*  (Thailand)

^d PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Menopause; Young coconut juice

Indexed keywords

AMYLOID BETA PROTEIN; ESTRADIOL BENZOATE; GLIAL FIBRILLARY ACIDIC PROTEIN; TAU PROTEIN; BIOLOGICAL MARKER; ESTRADIOL; PHYTOESTROGEN; PLANT MEDICINAL PRODUCT;

ALZHEIMER DISEASE; AMYLOIDOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; BRAIN CORTEX; CLINICAL FEATURE; COCONUT JUICE; CONTROLLED STUDY; DISEASE ASSOCIATION; ESTRADIOL BLOOD LEVEL; FEMALE; FRUIT JUICE; HIPPOCAMPUS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; RISK REDUCTION; TAUOPATHY; THERAPY EFFECT; ANIMAL; BLOOD; BRAIN; COCONUT; DRUG EFFECT; METABOLISM; NEUROFIBRILLARY TANGLE; NUT; OVARIECTOMY; PATHOLOGY; PHYTOTHERAPY; WISTAR RAT;

RATTUS;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BIOLOGICAL MARKERS; BRAIN; COCOS; ESTRADIOL; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; NEUROFIBRILLARY TANGLES; NUTS; OVARIECTOMY; PHYTOESTROGENS; PHYTOTHERAPY; PLANT PREPARATIONS; RATS; RATS, WISTAR; TAU PROTEINS;

EID: 79953137074     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114510004241     Document Type: Article

References (41)

1. Christiansen C & Lindsay R (1990) Estrogen, bone loss and preservation. Osteoporosis Int 1, 7-13.
2. Gibbs RB & Aggarwal P (1998) Estrogen and basal forebrain cholinergic neurons: implications for brain aging and Alzheimer'sdisease-related cognitive decline. Horm Behav 34, 98-111.
3. McEwen BS & Alves SE (1999) Estrogen actions in the central nervous system. Endocr Rev 20, 279-307.
4. Solerte SB, Fioravanti M, Racchi M, et al. (1999) Menopause and estrogen deficiency as a risk factor in dementing illness: hypothesis on the biological basis. Maturitas 31, 95-101.
5. Radenahmad N, Saleh F, Sawangjaroen K, et al. (2009) Young coconut juice significantly reduces histopathological changes in the brain that is induced by hormonal imbalance: a possible implication to postmenopausal women. Histol Histopathol 24, 667-674.
6. Gibbs RB (1996) Expression of estrogen receptor-like immunoreactivity by different subgroups of basal forebrain cholinergic neurons in gonadectomized male and female rats. Brain Res 720, 61-68.
7. Gibbs RB (1997) Effects of estrogen on basal forebrain cholinergic neurons vary as a function of dose and duration of treatment. Brain Res 757, 10-16.
8. Monk D & Brodaty H (2000) Use of estrogens for the prevention and treatment of Alzheimer's disease. Dement Geriatr Cogn 11, 1-10.
9. Breteler MM, Claus JJ, Grobbee DE, et al. (1994) Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam Study. Br Med J 308, 1604-1608.
10. Birge SJ (1996) Is there a role for estrogen replacement therapy in the prevention and treatment of dementia? J Am Geriatr Soc 44, 865-870.
11. Yaffe K, Sawaya G, Lieberburg I, et al. (1998) Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. J Am Med Assoc 279, 688-695.
12. Henderson VW (1997) Estrogen, cognition, and a woman'srisk of Alzheimer's disease. Am J Med 103, 11S-18S.
13. Bhavnani BR (2003) Estrogens and menopause: pharmacology of conjugated equine estrogens and their potential role in the prevention of neurodegenerative diseases such as Alzheimer's. J Steroid Biochem Mol Biol 85, 473-482.
14. Casadesus G, Rolston RK, Webber KM, et al. (2008) Menopause, estrogen, and gonadotropins in Alzheimer's disease. Adv Clin Chem 45, 139-153.
15. Yaffe K, Lui LY, Grady D, et al. (2000) Cognitive decline in women in relation to non-protein-bound estradiol concentration. Lancet 356, 708-712.
16. Paganini-Hill A & Henderson VW (1994) Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol 140, 256-261.
17. Paganini-Hill A & Henderson VW (1996) Estrogen replacement therapy and risk of Alzheimer disease. Arch Intern Med 156, 2213-2217.
18. Waring SC, Rocca WA, Petersen RC, et al. (1999) Postmenopausal estrogen replacement therapy and risk of AD: a population- basic study. Neurology 52, 965-970.
19. Shankar GM, Li S, Mehta TH, et al. (2008) Amyloid-protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 14, 837.
20. Hartmann T, Bieger SC & Brühl B (1997) Distinct sites of intracellular production for Alzheimer's disease Ab40/42 amyloid peptides. Nat Med 3, 1016-1020.
21. Yin YI, Bassit B, Zhu L, et al. (2007) g-Secretase substrate concentration modulates the Ab42/Ab40 ratio: implications for Alzheimer's disease. J Biol Chem 282, 23639-23644.
22. Inagaki M, Gonda Y, Nishizawa K, et al. (1990) Phosphorylation sites linked to glial filament disassembly in vitro locate in a non-alpha-helical head domain. J Biol Chem 265, 4722-4729.
23. Hernández F & Avila J (2007) Tauopathies. Cell Mol Life Sci 64, 2219-2233.
24. Punghmatharith B (1988) Sex hormone-like substances in young coconut juice and their effects on uterine growth in rats. Songklanakarin J Sci Tech 10, 221-226.
25. Radenahmad N, Vongvatcharanon U, Withyachumnarnkul B, et al. (2006) Serum levels of 17b-estradiol in ovariectomized rats fed young-coconut juice and its effect on wound healing. Songklanakarin J Sci Tech 28, 897-910.
26. Paxinos G & Watson C (1986) Stereotaxic coordinates. In The Rat Brain, 2nd ed., pp. 38-89 [G Paxinos and C Watsons, editors]. San Diego, CA: Academic Press, Inc.
27. Tang MX, Jacobs D, Stern Y, et al. (1996) Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 348, 429-432.
28. Melton L (2000) Sex is all in the brain: report of a Novartis Foundation Symposium on the neuronal and cognitive effects of oestrogens. Trends Endocrinol Metab 11, 69-71.
29. Hashimoto M, Rockenstein E, Crews L, et al. (2003) Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases. Neuromolecular Med 4, 21-36.
30. Selkoe DJ (1999) Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 399, A23-A31.
31. Turner PR, O'Connor K, Tate WP, et al. (2003) Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory. Prog Neurobiol 70, 1-32.
32. Hooper NM (2005) Roles of proteolysis and lipid rafts in the processing of the amyloid precursor protein and prion protein. Biochem Soc Trans 33, 335-338
33. Priller C, Bauer T, Mitteregger G, et a . (2006) Synapse formation and function is modulated by the amyloid precursor protein. J Neurosci 26, 7212-7221.
34. Chambers CB, Sigurdsson EM, Hejna MJ, et al. (2000) Amyloid- b injection in rat amygdala alters tau protein but not mRNA expression. Exp Neurol 162, 158-170.
35. Probst P, Gotz J, Wi Ederhold KH, et al. (2000) Axonopathy and amyopathy in mice transgenic for human four-repeat tau protein. Acta Neuropathol 99, 469-481.
36. Gotz J (2001) Tau and transgenic animal models. Brain Res 35, 266-286.
37. Calhoun ME, Burgermeister P, Phinney AL, et al. (1999) Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. Proc Natl Acad Sci U S A 96, 14088-14093.
38. Van Dorpe J, Smeijers L, Dewachter I, et al. (2000) Prominent cerebral amyloid angiopathy in transgenic mice overexpression the London mutant of human APP in neurons. Am J Pathol 157, 1283-1298.
39. Cadavid D, Mena H, Koeller K, et al. (2000) Cerebral beta amyloid angiopathy is a risk factor for cerebral ischemic infarction. A case control study in human brain biopsies. J Neuropathol Exp Neurol 52, 702-708.
40. Moghadasian MH (2000) Pharmacological properties of plant sterols in vivo and in vitro observations. Life Sci 67, 605-615.
41. Salah AM, Gathumbi J, Vierling W, et al. (2002) Estrogenic and cholinergic properties of the methanol extract of Ruellia praetermissa Sceinf. ex. Lindau (Acanthaceae) in female rats. Phytomedicine 9, 52-55.